Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution. It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011. In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country. DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations. Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.

1. Pediatric Vaccines Market, Doses, Immunization,
Cases and Forecast: Worldwide Analysis
Renub Research
www.renub.com
Published: December, 2012
Copyright © 2012 Renub Research – All Rights Reserved

2. © Renub Research Page 2 of 18
Pediatric Vaccines Market Analysis
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has
doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market
is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during
2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7,
Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than
60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines
market are expected to show stagnant growth in future due to lower margins and the mature
nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines
control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown
decline continuously from the year 2001 till 2011. Polio remains endemic merely in three
countries and the good news is that India has not reported a single case from the past two
years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less
than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used
vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine
although the price of Rotavirus vaccine has declined but still its present prices are expensive
than other pediatric vaccines. However despite all the impediments pediatric vaccines
industry is expected to remain highly active in the future, fueled by the encouragement and
financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and
Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides
information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of
Cases by region in the world. This report covers in detail all aspects of past, present and
future scenario. This report provides market landscape and market share information of the
Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary

3. © Renub Research Page 3 of 18
Vaccines Market. The report also entails major factors driving the pediatric vaccine market
and challenges of pediatric vaccine market.
Pediatric Vaccines Covered in this Report are as follows:
Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines,
Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines
Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other
Pediatric Vaccines
All the Pediatric Vaccines in this Report have been Studied from Four View Points:
 Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011
 Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015
 Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
 Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
Key Topics Covered in the Report
 Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)
 Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)
 Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)
 By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)
 By Region - Pediatric Disease Cases (2001 – 2011)
 Pediatric Vaccines Doses and Forecast (2005 – 2015)
 Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)
 All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)
 Growth Drivers of Pediatric Vaccines Market
 Challenges of Pediatric Vaccines Market

4. © Renub Research Page 4 of 18
Data Sources
This report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 100 paid databases.

5. © Renub Research Page 5 of 18
About Us
RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information
Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services
(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,
Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.
For more information on us or to view any of our sample work you can
mail us at info@renub.com

6. © Renub Research Page 6 of 18
Published
By
RReennuubb RReesseeaarrcchh
A–116B, Sector–27
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com
© Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis
Renub Research, 2012
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

7. © Renub Research Page 7 of 18
Table of Contents
1. Executive Summary
2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)
3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)
4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)
5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)
5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market
5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market
5.3 Worldwide – Pediatric Proprietary Vaccines Market
6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast
6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)
6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)
6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines
6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)
6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)
6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines
6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
6.3 Polio Vaccines and Forecast (2005 – 2015)
6.3.1 Number of Polio Cases (2001 – 2011)
6.3.2 Number of Polio Vaccines Doses
6.3.3 Immunization Coverage of Polio Vaccines
6.3.4 Market Size of Polio Vaccines
6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)
6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)
6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses
6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines
6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines
6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)

8. © Renub Research Page 8 of 18
6.5.1 Number of Pneumococcal Cases (2000)
6.5.2 Number of Pneumococcal Vaccines Doses
6.5.3 Immunization Coverage of Pneumococcal Vaccines
6.5.4 Market Size of Pneumococcal Vaccines
6.6 Rotavirus Vaccine and Forecast (2006 – 2015)
6.6.1 Number of Rotavirus Cases (2008 & 2009)
6.6.2 Number of Rotavirus Vaccines Doses
6.6.3 Immunization Coverage of Rotavirus Vaccines
6.6.4 Market Size of Rotavirus Vaccine
6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)
6.7.1 Number of Hepatitis Pediatric Vaccines Doses
6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines
6.7.3 Market Size of Hepatitis Pediatric Vaccines
6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)
6.8.1 Number of Varicella/Chicken Pox Vaccines Doses
6.8.2 Market Size of Varicella/Chicken Pox Vaccines
6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)
6.9.1 Market Size of Other Pediatric Vaccines
7. Growth Drivers of Pediatric Vaccines Market
7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be
Done Error! Bookmark not defined.
7.1.1 Rotavirus Vaccine Introduction
7.1.2 Financial Challenges
7.1.3 Cost Effective
7.1.4 Future Steps
7.1.5 Conclusion
7.2 GAVI Model Increases Vaccine Manufacturers
7.2.1 The Partnership Model
7.2.2 The Business Model
7.3 WHO Global Vaccine Action Plan (2011 - 2020)
8. Challenges of Pediatric Vaccine Market
8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines
8.2 Impediment in Pediatric Vaccine Research & Development

9. © Renub Research Page 9 of 18
8.3 Barriers to New Entrants in the Pediatric Vaccines Market

10. © Renub Research Page 10 of 18
List of Figures
Figure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011
Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011
Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –
2015
Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011
Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$),
2012 – 2015
Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011
Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$),
2012 – 2015
Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011
Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015
Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015
Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses),
2012 – 2015
Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011
Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 –
2015
Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income
Countries, 1980 – 2010
Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses),
2005 – 2011
Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines
(Million Doses), 2012 – 2015
Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million
Doses), 2005 – 2011
Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B
Vaccines (Million Doses), 2012 – 2015
Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 –
2011
Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million
US$), 2012 – 2015

11. © Renub Research Page 11 of 18
Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015
Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 –
2015
Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011
Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015
Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015
Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 –
2015
Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005
– 2011
Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market
(Million US$), 2012 – 2015
Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025
Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011
Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012
– 2015
Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 –
2011
Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million
Doses), 2012 – 2015
Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011
Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015
Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 –
2015
Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses),
2012 – 2015
Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011
Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015
Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011
Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses),
2012 – 2015

12. © Renub Research Page 12 of 18
Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 –
2011
Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million
Doses), 2012 – 2015
Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010
Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011
Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 –
2015
Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011
Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015
Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 7-1: Prices of Childhood Vaccines (US$), 2011
Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012
Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets

13. © Renub Research Page 13 of 18
List of Tables
Table 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011
Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –
2015
Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011
Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011
Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011
Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis
Cases (Number), 2001 – 2011
Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011
Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011
Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011
Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011
Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011
Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5
Years of Age (Number), 2000
Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number),
2008 – 2009
Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive
Cases (Number & Percent), 2009
Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020
Table 7-2: Goal-Level Indicators, 2015 & 2020

14. © Renub Research Page 14 of 18
Related Reports
Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable
Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device)
Market Forecast, Clinical Trials, M&A
Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)
Asia Medical Tourism Analysis and Forecast to 2015
Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis
Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016
Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
Genetic Testing Market and Forecast - Global Analysis 2010 – 2015
USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies &
Clinical Trials) to 2017: Global Analysis
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs
Analysis
Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,
Challenges & Future Forecast

15. © Renub Research Page 15 of 18
Our Partial List of Clients
Bain
WAKE Technology Services, Inc.
PSS World Medical
Relypsa
C&K components
Konkuk University
Resonetics
Samsung
SEKISUI MEDICAL CO. LTD.
Plentyoffish Media INC
Arthur D Little Gmbh
Morgan Stanley
Takeda Pharmaceutical Corporation
Hokkai School of Commerce
Ministry of Manpower Singapore
GenOmind, LLC.
Goldman Sachs & Co
NTT Advanced Technology
Tokyo Womens Medical University
The Chemo-Sero-Therapeutic Research
Trade Council of Iceland
Jpmorgan, Ets Trading
GE Healthcare IT
ixia communications
Redbus
Becton Dickinson
Pfizer
Intercell
Sanofi Pasteur
Stanford Burgess
Pequot Capital
DMI
Transgene S.A.
ixia communications
Toyota Tsusho Amercia Inc.
National Health Research Institutes
Abbott Diabetes Care
Corning Incorporated - Life Sciences
L.E.K. Consulting GmbH
Syntiron
MediVas LLC
Credit Suisse
Dune Medical
QIAGEN
Inje University
Mapp Biopharmaceutical
Institute for Information Industry
NorDiag ASA
Rep e Inv Medicas SA de
Innogenetics

16. © Renub Research Page 16 of 18
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide
Analysis
Single User
(Email from Publisher)
Hard Copy
(Mail Delivery)
CD – Rom
(Mail Delivery)
Global Site License
(Multiple User License)
US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-
forecast-worldwide-analysis-86
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325
To pay by Wire Transfer, please, fill in your contact details in the form below:

17. © Renub Research Page 17 of 18
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th
Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

18. © Renub Research Page 18 of 18
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
A -116B
Sector -27
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch